CLOV vs REZI · rev $1.37B vs P/E 75, rev $6.76B
Clover Health Investments Corp (CLOV) versus Resideo Technologies Inc (REZI) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Resideo Technologies Inc (REZI) is a industrial distribution company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported REZI revenue for 2024-12-31 was $6.76B. Net income was $116.0M. Revenue was up 8.3% from 2023-12-31 to 2024-12-31. REZI currently screens at market cap $3.44B and trailing P/E 74.7.
CLOV currently screens at market cap $1.55B. REZI currently screens at market cap $3.44B and trailing P/E 74.7.
Not investment advice. Open the CLOV and REZI stock pages for the full models.
Not investment advice.